<?xml version="1.0" encoding="ISO-8859-1"?>

<rdf:RDF
 xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
 xmlns="http://purl.org/rss/1.0/"
 xmlns:content="http://purl.org/rss/1.0/modules/content/"
 xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/"
 xmlns:dc="http://purl.org/dc/elements/1.1/"
 xmlns:syn="http://purl.org/rss/1.0/modules/syndication/"
 xmlns:prism="http://purl.org/rss/1.0/modules/prism/"
 xmlns:admin="http://webns.net/mvcb/"
>

<channel rdf:about="http://thorax.bmj.com/">
<title>Thorax: Most-Read Full-Text Articles</title>
<link>http://thorax.bmj.com/</link>
<description>Most-read rankings are recalculated at the beginning of the month based on usage of full-text and PDF views for the previous month.</description>
<prism:coverDisplayDate>2013-05-08</prism:coverDisplayDate>
<items>
 <rdf:Seq>
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/4/322?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/2/155?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/5/475?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/67/11/957?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/3/283?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/3/214?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/5/404?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/thoraxjnl-2013-203534v1?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/68/5/436?rss=1&#x26;amp;ssource=mfr" />
  <rdf:li rdf:resource="http://thorax.bmj.com/cgi/content/short/thoraxjnl-2012-202606v1?rss=1&#x26;amp;ssource=mfr" />
 </rdf:Seq>
</items>
</channel>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/4/322?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/4/322?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Guy G Brusselle, Christine VanderStichele, Paul Jordens, Rene Deman, Hans Slabbynck, Veerle Ringoet, Geert Verleden, Ingel K Demedts, Katia Verhamme, Anja Delporte, Benedicte Demeyere, Geert Claeys, Jerina Boelens, Elizaveta Padalko, Johny Verschakelen, Georges Van Maele, Ellen Deschepper, Guy F P Joos<br />Apr  1, 2013; 68:322-329<br />Asthma]]></description>
<dc:creator>Guy G Brusselle, Christine VanderStichele, Paul Jordens, Rene Deman, Hans Slabbynck, Veerle Ringoet, Geert Verleden, Ingel K Demedts, Katia Verhamme, Anja Delporte, Benedicte Demeyere, Geert Claeys, Jerina Boelens, Elizaveta Padalko, Johny Verschakelen, Georges Van Maele, Ellen Deschepper, Guy F P Joos</dc:creator>
<dc:date>2013-04-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial]]></dc:title>
<prism:number>4</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>329</prism:endingPage>
<prism:publicationDate>2013-04-01</prism:publicationDate>
<prism:section>Asthma</prism:section>
<prism:startingPage>322</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/2/155?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/2/155?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Ludmila Shulgina, Anthony P Cahn, Edwin R Chilvers, Helen Parfrey, Allan B Clark, Edward C F Wilson, Orion P Twentyman, Anthony G Davison, John J Curtin, Michael B Crawford, Andrew M Wilson<br />Feb  1, 2013; 68:155-162<br />Interstitial lung disease]]></description>
<dc:creator>Ludmila Shulgina, Anthony P Cahn, Edwin R Chilvers, Helen Parfrey, Allan B Clark, Edward C F Wilson, Orion P Twentyman, Anthony G Davison, John J Curtin, Michael B Crawford, Andrew M Wilson</dc:creator>
<dc:date>2013-02-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Treating idiopathic pulmonary fibrosis with the addition of co-trimoxazole: a randomised controlled trial]]></dc:title>
<prism:number>2</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>162</prism:endingPage>
<prism:publicationDate>2013-02-01</prism:publicationDate>
<prism:section>Interstitial lung disease</prism:section>
<prism:startingPage>155</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/5/475?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/5/475?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Maria Pierro, Lavinia Ionescu, Tiziana Montemurro, Arul Vadivel, Gaia Weissmann, Gavin Oudit, Derek Emery, Sreedhar Bodiga, Farah Eaton, Bruno Peault, Fabio Mosca, Lorenza Lazzari, Bernard Thebaud<br />May  1, 2013; 68:475-484<br />Stem cell biology]]></description>
<dc:creator>Maria Pierro, Lavinia Ionescu, Tiziana Montemurro, Arul Vadivel, Gaia Weissmann, Gavin Oudit, Derek Emery, Sreedhar Bodiga, Farah Eaton, Bruno Peault, Fabio Mosca, Lorenza Lazzari, Bernard Thebaud</dc:creator>
<dc:date>2013-05-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Short-term, long-term and paracrine effect of human umbilical cord-derived stem cells in lung injury prevention and repair in experimental bronchopulmonary dysplasia]]></dc:title>
<prism:number>5</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>484</prism:endingPage>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Stem cell biology</prism:section>
<prism:startingPage>475</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/67/11/957?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality]]></title>
<link>http://thorax.bmj.com/cgi/content/short/67/11/957?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Samy Suissa, Sophie Dell''Aniello, Pierre Ernst<br />Nov  1, 2012; 67:957-963<br />Chronic obstructive pulmonary disease]]></description>
<dc:creator>Samy Suissa, Sophie Dell&#x27;&#x27;Aniello, Pierre Ernst</dc:creator>
<dc:date>2012-11-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality]]></dc:title>
<prism:number>11</prism:number>
<prism:volume>67</prism:volume>
<prism:endingPage>963</prism:endingPage>
<prism:publicationDate>2012-11-01</prism:publicationDate>
<prism:section>Chronic obstructive pulmonary disease</prism:section>
<prism:startingPage>957</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/3/283?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Advances in tuberculosis 2011-2012]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/3/283?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Heather J Zar, Zarir F Udwadia<br />Mar  1, 2013; 68:283-287<br />Reviews]]></description>
<dc:creator>Heather J Zar, Zarir F Udwadia</dc:creator>
<dc:date>2013-03-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Advances in tuberculosis 2011-2012]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>287</prism:endingPage>
<prism:publicationDate>2013-03-01</prism:publicationDate>
<prism:section>Reviews</prism:section>
<prism:startingPage>283</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/3/214?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/3/214?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Maria Eugenia Jimenez-Corona, Luis Pablo Cruz-Hervert, Lourdes Garcia-Garcia, Leticia Ferreyra-Reyes, Guadalupe Delgado-Sanchez, Miriam Bobadilla-del-Valle, Sergio Canizales-Quintero, Elizabeth Ferreira-Guerrero, Renata Baez-Saldana, Norma Tellez-Vazquez, Rogelio Montero-Campos, Norma Mongua-Rodriguez, Rosa Areli Martinez-Gamboa, Jose Sifuentes-Osornio, Alfredo Ponce-de-Leon<br />Mar  1, 2013; 68:214-220<br />Tuberculosis]]></description>
<dc:creator>Maria Eugenia Jimenez-Corona, Luis Pablo Cruz-Hervert, Lourdes Garcia-Garcia, Leticia Ferreyra-Reyes, Guadalupe Delgado-Sanchez, Miriam Bobadilla-del-Valle, Sergio Canizales-Quintero, Elizabeth Ferreira-Guerrero, Renata Baez-Saldana, Norma Tellez-Vazquez, Rogelio Montero-Campos, Norma Mongua-Rodriguez, Rosa Areli Martinez-Gamboa, Jose Sifuentes-Osornio, Alfredo Ponce-de-Leon</dc:creator>
<dc:date>2013-03-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Association of diabetes and tuberculosis: impact on treatment and post-treatment outcomes]]></dc:title>
<prism:number>3</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>220</prism:endingPage>
<prism:publicationDate>2013-03-01</prism:publicationDate>
<prism:section>Tuberculosis</prism:section>
<prism:startingPage>214</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/5/404?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Macrolides and pneumonia]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/5/404?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Jeremy Stuart Brown, Adam T Hill<br />May  1, 2013; 68:404-405<br />]]></description>
<dc:creator>Jeremy Stuart Brown, Adam T Hill</dc:creator>
<dc:date>2013-05-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Macrolides and pneumonia]]></dc:title>
<prism:number>5</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>405</prism:endingPage>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section></prism:section>
<prism:startingPage>404</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/thoraxjnl-2013-203534v1?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Daily physical activity in subjects with newly diagnosed COPD]]></title>
<link>http://thorax.bmj.com/cgi/content/short/thoraxjnl-2013-203534v1?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Hans Van Remoortel, Miek Hornikx, Heleen Demeyer, Daniel Langer, Chris Burtin, Marc Decramer, Rik Gosselink, Wim Janssens, Thierry Troosters<br />Apr 20, 2013; 0:201320353-201320353<br />PostScript]]></description>
<dc:creator>Hans Van Remoortel, Miek Hornikx, Heleen Demeyer, Daniel Langer, Chris Burtin, Marc Decramer, Rik Gosselink, Wim Janssens, Thierry Troosters</dc:creator>
<dc:date>2013-04-20</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Daily physical activity in subjects with newly diagnosed COPD]]></dc:title>
<prism:number>2013</prism:number>
<prism:volume>0</prism:volume>
<prism:endingPage>201320353</prism:endingPage>
<prism:publicationDate>2013-04-20</prism:publicationDate>
<prism:section>PostScript</prism:section>
<prism:startingPage>201320353</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/68/5/436?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis]]></title>
<link>http://thorax.bmj.com/cgi/content/short/68/5/436?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[Carmel J Stock, Hiroe Sato, Carmen Fonseca, Winston A S Banya, Philip L Molyneaux, Huzaifa Adamali, Anne-Marie Russell, Christopher P Denton, David J Abraham, David M Hansell, Andrew G Nicholson, Toby M Maher, Athol U Wells, Gisela E Lindahl, Elisabetta A Renzoni<br />May  1, 2013; 68:436-441<br />Interstitial lung disease]]></description>
<dc:creator>Carmel J Stock, Hiroe Sato, Carmen Fonseca, Winston A S Banya, Philip L Molyneaux, Huzaifa Adamali, Anne-Marie Russell, Christopher P Denton, David J Abraham, David M Hansell, Andrew G Nicholson, Toby M Maher, Athol U Wells, Gisela E Lindahl, Elisabetta A Renzoni</dc:creator>
<dc:date>2013-05-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis]]></dc:title>
<prism:number>5</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>441</prism:endingPage>
<prism:publicationDate>2013-05-01</prism:publicationDate>
<prism:section>Interstitial lung disease</prism:section>
<prism:startingPage>436</prism:startingPage>
</item>
<item rdf:about="http://thorax.bmj.com/cgi/content/short/thoraxjnl-2012-202606v1?rss=1&#x26;amp;ssource=mfr">
<title><![CDATA[Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the {beta}2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial]]></title>
<link>http://thorax.bmj.com/cgi/content/short/thoraxjnl-2012-202606v1?rss=1&#x26;amp;ssource=mfr</link>
<description><![CDATA[William W Busse, Paul M O''Byrne, Eugene R Bleecker, Jan Lotvall, Ashley Woodcock, Leslie Andersen, Wesley Hicks, Jodie Crawford, Loretta Jacques, Ludovic Apoux, Eric D Bateman<br />Jun  1, 2013; 68:513-520<br />Asthma]]></description>
<dc:creator>William W Busse, Paul M O&#x27;&#x27;Byrne, Eugene R Bleecker, Jan Lotvall, Ashley Woodcock, Leslie Andersen, Wesley Hicks, Jodie Crawford, Loretta Jacques, Ludovic Apoux, Eric D Bateman</dc:creator>
<dc:date>2013-06-01</dc:date>
<dc:publisher>BMJ Publishing Group Ltd</dc:publisher>
<dc:title><![CDATA[Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the {beta}2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial]]></dc:title>
<prism:number>6</prism:number>
<prism:volume>68</prism:volume>
<prism:endingPage>520</prism:endingPage>
<prism:publicationDate>2013-06-01</prism:publicationDate>
<prism:section>Asthma</prism:section>
<prism:startingPage>513</prism:startingPage>
</item>
</rdf:RDF>